PAK1调控GATA1的降解在原发性骨髓纤维化中的作用和机制研究
批准号:
82070131
项目类别:
面上项目
资助金额:
55.0 万元
负责人:
付春玲
依托单位:
学科分类:
骨髓增殖性肿瘤
结题年份:
2024
批准年份:
2020
项目状态:
已结题
项目参与者:
付春玲
中文摘要
原发性骨髓纤维化(PMF)是骨髓增殖性肿瘤(MPN)中预后最差的类型,严重影响患者生活质量,重者危及生命。巨核细胞异常累积是诱导PMF发病的重要因素,诱导异常巨核细胞分化是潜在的治疗PMF的新途径。然而,由于PMF巨核细胞异常分化机制不清,严重制约其靶向干预治疗的探索。有研究显示,GATA1是调控造血干细胞向巨核-红系细胞分化的关键转录因子,但在PMF巨核细胞中缺失。我们前期研究发现,PAK1是调控GATA1降解的关键激酶,在PMF细胞中过度活化,故推测:PAK1是调控PMF巨核细胞中GATA1缺失的重要激酶,参与调节PMF的发生发展。为此,本课题拟建立小鼠巨核细胞中敲除PAK1基因的PMF模型,从细胞和在体水平,明确PAK1调控GATA1的位点、及其调控PMF巨核细胞GATA1表达的分子机制。如获成功,可为从翻译后调控解析PMF发生发展提供可靠的实验依据。
英文摘要
Primary myelofibrosis(PMF), as one type of myeloproliferative tumor (MPN), has the worst prognosis, which seriously affects the quality of life of patients, even has life-threatening risk. The abnormal accumulation of megakaryocytes directly promote the progress of PMF, and induction of megakaryocytic differentiation is considered to be a novel strategy to therapy PMF. However, the unclear mechanism in megakaryocytic differentiation seriously restricts to explore new strategy for targeting treatment of PMF. As the report, GATA1 plays an important role during the differentiation of hematopoietic stem cells to megakaryocyte-erythroid cells, but is founded lost expression in PMF megakaryocyte. In our previous study, we found that PAK1 was activated in PMF cells, and was a pivotal kinase for regulation of GATA1 degradation. Here, we further speculate that PAK1 directly induces GATA1 lost expression in PMF megakaryocyte, and contributes to the development of PMF. Next, we plan to verify the regulatory site of GATA1 by PAK1, and explore the molecule mechanism that PAK1 regulates GATA1 expression by PAK1-/- PMF mouse model in vitro and in vivo. Once successfully, this project can provide conclusive results for explanation of PMF occurrence and development from post-translation level.
原发性骨髓纤维化(PMF)是骨髓增殖性肿瘤(MPN)中预后最差的类型,严重影响患者生活质量。巨核细胞异常累积是诱导PMF发病的重要因素,诱导异常巨核细胞分化是治疗PMF的新途径。然而,由于PMF巨核细胞异常分化机制不清,严重制约其治疗策略探索。本研究中发现,PAK1激酶在PMF患者及巨核细胞中被过度激活,抑制PAK1激酶的活性抑制PMF巨核细胞增殖及克隆形成,降低了S期巨核细胞的比例、下调细胞周期蛋白的表达,促进PMF巨核细胞分化、诱导细胞凋亡。体内研究显示,PKA1激酶抑制剂缓解PMF移植小鼠脾肿大的症状、并延长存活时间。敲低PAK1基因能够改善移植小鼠骨髓造血、显著能够延长小鼠存活时间。尽管敲除PAK1基因可在疾病初期改善血象,不能完全缓解脾肿大,但可改善PMF移植小鼠脾脏结构及巨核细胞的累积。进一步研究显示,PAK1是调控GATA1泛素化降解的关键激酶,GATA1是调控造血干细胞向巨核-红系细胞分化的关键转录因子,但在PMF巨核细胞中缺失。抑制PAK1激酶活性恢复GATA1在PMF巨核细胞中缺失性表达。综上,本研究得出以下结论:PAK1激酶在PMF中过度激活,促进了GATA1的磷酸化,进而泛素化降解,致使其缺失性表达,巨核细胞异常发育。抑制PAK1激酶活性,可通过恢复GATA1的表达水平,促进巨核细胞的分化,凋亡, 并缓解PMF移植小鼠的疾病进展。本研究为从翻译后调控解析PMF发生提供可靠实验依据。
COP1通过p53—Brn-3a调控Bcl-2的表达在CLL发病中的作用机制研究
-
批准号:81400127
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2014
-
负责人:付春玲
-
依托单位:
国内基金
海外基金